Korro Bio, Inc. Grants Receivable, Current
Korro Bio, Inc. (KRRO) had Grants Receivable, Current of $246.00 thousand as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Notes
us-gaap:GrantsReceivableCurrent · last filed 2021-03-29
- 2020-03-31: Grants Receivable, Current $246.00K.
- 2019-12-31: Grants Receivable, Current $805.00K.
- 2019-09-30: Grants Receivable, Current $408.00K.
- 2018-12-31: Grants Receivable, Current $161.00K.
| Period end | Grants Receivable, Current |
|---|---|
| 2020-03-31 | $246.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $805.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $408.00K 10-Q · filed 2019-11-18 |
| 2018-12-31 | $161.00K 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |